|
|
||||||||
|
|
|||||||||
|
|
General Clinical Specialties: Infectious Disease/HematologyInfectious Disease/Hematology Posters |
1 Medicina Nucleare, Ospedale S. Maria della Misericordia, Rovigo, Italy; 2 Polclinico S. Orsola Malpighi Bologna, Bologna, Italy
1136
Objectives: To evaluate efficacy of a dual-time acquisition protocol combined with semiquantitative ROI analysis with LeukoScan in the diagnosis of infection in painful hip prosthesis.
Methods: 67 pts were enrolled. All pts had clinical and biochemical suspicious of infection; prosthesis had been implanted 3 mo. to 12 yrs. 24 pts were on antibiotic therapy. Both early 4 hr and delayed 20-24 hr LeukoScan imaging was obtained. For semiquantitative approach, ROI analysis was used in the anterior views to measure the mean radioactivity in the prosthesis by a square ROI method to which BKG measured on the femur was subtracted. A stable or increasing trend in intensity of uptake of at least 20% at the dual-time LeukoScan was considered consistent, while a decreasing pattern was judged a negative result. Final diagnosis was obtained at surgery and/or prolonged clinical and imaging follow-up.
Results: At visual analysis, sensitivity for early and delayed imaging were 94%, specificity was 71% for early imaging and 83% for early and delayed imaging approach. At semiquantitative analysis, sensitivity remains 94%, specificity was 73% for early imaging and 90% for early and delayed imaging approach. 4 false positive early scans were correctly diagnosed as negative at delayed imaging. No differences were observed between pts on or off antibiotic therapy.
Conclusions: Thus, delayed LeukoScan imaging is important in identifying false positive results detect at early imaging. Thus, a dual-time, early and delayed LeukoScan imaging approach is strongly recommended to increase the diagnostic accuracy. The semiquantitative analysis approach we adopted proved to further increase the specificity of the method.
| ||||||||||||||||||||||||||||||||||||||